Article

Beckman Coulter Life Sciences has partnered with Automata to integrate its liquid handling and cell analysis technologies with Automata's AI-ready automation platform, aiming to enhance experimentation speed and scalability for research organizations. This collaboration will be implemented within Automata's LINQ automation ecosystem, which includes intelligent robotics and flexible workflow design. Additionally, Danaher Corporation has invested in Automata's Series C funding round, with Danaher Ventures joining Automata's board to foster future innovation.